Skip to content

DMT: all studies

Page 32 of 160: studies 311 to 320 of 1,593, newest first. Back to the DMT overview

Research

Neural correlates of the DMT experience assessed with multivariate EEG.

Scientific Reports November 19, 2019 Christopher Timmermann, Leor Roseman, Michael Schartner et al. 325 citations

Studying transitions in and out of the altered state of consciousness caused by intravenous (IV) N,N-Dimethyltryptamine (DMT - a fast-acting tryptamine psychedelic) offers a safe and powerful means of advancing knowledge on the neurobiology of conscious states. Here we sought to investigate the effects of IV DMT on the power spectrum and signal diversity of human brain activity (6 female, 7...

Syrian rue seeds interacted with acacia tree bark in an herbal stew resulted in N,N-dimethyltryptamine poisoning.

Clinical Toxicology October 1, 2019 Chuan-Huai Liu, Wei-Lan Chu, Shu-Chen Liao et al. 10 citations

Introduction: Illicit substance use is an increasing problem all over the world, especially in adolescents and young adults. It is a challenge to make a definitive diagnosis of a specific substance in a poisoning case without toxicology laboratory confirmation. We confirmed the presence of N,N-dimethyltryptamine (DMT) by liquid chromatograph tandem mass spectrometer (LC/MS/MS) in biologic...

5-Methoxy-N,N-dimethyltryptamine: An Ego-Dissolving Endogenous Neurochemical Catalyst of Creativity

Activitas Nervosa Superior August 22, 2019 Christopher B. Germann 10 citations

Abstract 5-Methoxy-N,N-dimethyltryptamine (acronymized as 5-MeO-DMT) is sui generis among the numerous naturally-occurring psychoactive substances due to its unparalleled ego-dissolving effects which can culminate in a state of nondual consciousness (which is phenomenologically similar to transformative peak experiences described in various ancient contemplative traditions, e.g., Advaita...

The fumarate salts of the N-isopropyl-N-methyl derivatives of DMT and psilocin

Acta Crystallographica. Section E, Crystallographic Communications August 15, 2019 Andrew R Chadeayne, Duyen N. K. Pham, James A. Golen et al. 10 citations

The solid-state structures of the salts of two substituted tryptamines, namely N -isopropyl- N -methyltryptaminium (MiPT) fumarate {systematic name: [2-(1 H -indol-3-yl)ethyl](methyl)propan-2-ylazanium 3-carboxyprop-2-enoate}, C 14 H 21 N 2 + ·C 4 H 3 O 4 − , and 4-hydroxy- N -isopropyl- N -methyltryptaminium (4-HO-MiPT) fumarate monohydrate {systematic name: [2-(4-hydroxy-1 H...

DOI: 10.1107/s2056989019011253 (opens in new tab) Full text (opens in new tab) Isopropyl Stereochemistry Medicinal chemistry Organic chemistry

Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain.

Scientific Reports June 27, 2019 Jon G Dean, Tiecheng Liu, Sean Huff et al. 111 citations

N,N-dimethyltryptamine (DMT), a psychedelic compound identified endogenously in mammals, is biosynthesized by aromatic-L-amino acid decarboxylase (AADC) and indolethylamine-N-methyltransferase (INMT). Whether DMT is biosynthesized in the mammalian brain is unknown. We investigated brain expression of INMT transcript in rats and humans, co-expression of INMT and AADC mRNA in rat brain and...

N,N-dimethyltryptamine Prevents Renal Ischemia-Reperfusion Injury in a Rat Model.

Transplantation Proceedings May 1, 2019 B. Nemes, K. Peto, N. Németh et al. 21 citations

BACKGROUND Ischemia reperfusion (I/R) injury remains one of the most challenging fields of organ transplantation. It is highly associated with the use of expanded criteria donors that might conclude to delayed graft function or early or late graft failure. OBJECTIVE To investigate the metabolic, microcirculatory parameters, and histologic changes under the effect of N,N-dimethyltryptamine (DMT)...

Dimethyltryptamine: Endogenous Role and Therapeutic Potential

Journal of Psychoactive Drugs April 25, 2019 Alexandra Vsl Rodrigues, Francisco Almeida, Maria Augusta Vieira‐coelho 30 citations

N, N-dimethyltryptamine (DMT) is an indole alkaloid produced by a number of plants and animals, including humans. Its psychoactive effects were first described in 1956 by Stephen Szára, but have been exploited for centuries by South American indigenous populations in the form of ayahuasca. In the present review, we assess the state of the art regarding a putative role for endogenous DMT and...

Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT

PLoS One April 23, 2019 Roland R. Griffiths, Ethan Hurwitz, Alan K. Davis et al. 249 citations

Naturally occurring and psychedelic drug-occasioned experiences interpreted as personal encounters with God are well described but have not been systematically compared. In this study, five groups of individuals participated in an online survey with detailed questions characterizing the subjective phenomena, interpretation, and persisting changes attributed to their single most memorable God...

A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.

Psychopharmacology April 13, 2019 Malin V. Uthaug, R. Lancelotta, Kim van Oorsouw et al. 198 citations

Background: 5-methoxy-N,N-dimethyltryptamine (hereinafter referred to as 5-MeO-DMT) is a psychedelic substance found in the secretion from the parotoid glands of the Bufo alvarius toad. Inhalation of vapor from toad secretion containing 5-MeO-DMT has become popular in naturalistic settings as a treatment of mental health problems or as a means for spiritual exploration. However, knowledge of...

DOI: 10.1007/s00213-019-05236-w (opens in new tab) Full text (opens in new tab) Mental health Psychological health Emotional well-being Mental wellness +25